Clinical Trials Directory

Trials / Completed

CompletedNCT03776253

Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer

Conquer Fear SUPPORT: A Psychosocial Intervention in Patients With Advanced Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
City of Hope Medical Center · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This trial will pilot a psychosocial intervention called Conquer Fear Support (CFS) in patients with stage III-IV lung or gynecologic cancer who are experiencing fear of cancer progression. The intervention is adapted from a novel program called "Conquer Fear" which was developed by researchers in Australia. CFS may help in reducing worries, fears, and uncertainty in patients with advanced lung or gynecological cancer.

Detailed description

PRIMARY OBJECTIVES: I. Assess the feasibility and acceptability of the CFS intervention in patients with advanced lung and gynecologic (GYN) cancer (stages III or IV) who have clinically significant levels of fear of cancer progression (FOP) or cancer-related distress. SECONDARY OBJECTIVES: I. Assess preliminary effects of the intervention on FOP, cancer-specific distress, anxiety, depression, overall symptom distress, metacognitions, and mindfulness. OUTLINE: Patients attend CFS psychosocial intervention consisting of 7 nurse-led sessions (session 1 in-person and sessions 2-7 via video conferencing) over 45 minutes each for 8 weeks. Patients also complete home practice assignments comprising attention training technique and mindfulness practice sessions after each session. After completion of study intervention, patients are followed up at week 12.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPsychosocial Care Conquer Fear Support intervention (psychoeducation, attention training, worry management, and detached mindfulness components)Attend CFS
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2018-11-15
Primary completion
2024-07-26
Completion
2024-08-26
First posted
2018-12-14
Last updated
2025-01-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03776253. Inclusion in this directory is not an endorsement.